Effects of Gastric Inhibitory Polypeptide on Glucose and Lipid Metabolism of Isolated Rat Adipocytes
The DOI matches its Crossref record.
Abstract
The effects of gastric inhibitory polypeptide (GIP) on glucose and lipid metabolism of isolated rat adipocytes were investigated. In a dose-dependent manner, GIP stimulated 2-deoxy-glucose uptake increasing the glucose transport rate by up to 140% at a concentration of 10(-7) mol/l. GIP also stimulated the conversion of 14C-glucose into extractable lipids by up to 81% at 10(-7) mol/l. Insulin-stimulated 2-deoxy-glucose uptake and lipogenesis were additively enhanced by the presence of GIP. Insulin binding was slightly but not significantly increased by addition of GIP, mainly due to an increase in receptor affinity. GIP had a weak lipolytic activity, but lipolysis elicited by glucagon or isoproterenol was potently reduced. In conclusion, independent of its insulinotropic action, GIP showed a insulin-like activity on glucose metabolism and lipolysis in rat adipose tissue. The possible role of GIP for the development of obesity is discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The GCGR is potently downregulated during chronic kidney disease, and the lack of glucagon signaling in the kidney renders the tissue susceptible to fibrosis, inflammation, oxidative stress and lipid accumulation75.”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [75]
In the citing paper
“A recent report also puts forth potent reno-protective effects that are exerted through the GCGR in the kidney75.”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [75]
In the citing paper
“However, the presence of GIP-R on fat cells was shown in cell culture, animal and human models by gene expression and functional assays [103,104,105].”
From Adipose Tissue: A Novel Target of the Incretin Axis? A Paradigm Shift in Obesity-Linked Insulin Resistance (2024) · cites this paper as [103]
Citations
Cited by
Long-term persistence of hormonal adaptations to weight loss
Sumithran, P., Prendergast, L. A., Delbridge, E., Purcell, K., Shulkes, A., Kriketos, A., & Proietto, J. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105816 · Cited by 1,449
Nauck, M. A., Quast, D. R., Wefers, J., & Pfeiffer, A. F. H. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14496 · Cited by 388
Zhang, Q., Delessa, C. T., Augustin, R., Bakhti, M., Colldén, G., Drucker, D. J., Feuchtinger, A., Caceres, C. G., Grandl, G., Harger, A., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.01.015 · Cited by 322
The defence of body weight: a physiological basis for weight regain after weight loss
Sumithran, P., & Proietto, J. (2013) · Clinical Science · doi:10.1042/cs20120223 · Cited by 310
GIF biology and fat metabolism
Yip, R. G. C., & Wolfe, M. M. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00314-8 · Cited by 266
Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists
Liu, Q. K. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1431292 · Cited by 265
“Moreover, GIP has been found to boost glucose uptake by improving insulin sensitivity in adipocytes (176, 177), while tirzepatide has been demonstrated to enhance insulin sensitivity and promote glucose disposal in white adipose tissue in Glp-1r-null mice (178), further supporting a direct effect…”
BackgroundKetosis and appetite-mediating nutrients and hormones after weight loss
Sumithran, P., Prendergast, L. A., Delbridge, E., Purcell, K., Shulkes, A., Kriketos, A., & Proietto, J. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.90 · Cited by 260
Killion, E. A., Wang, J., Yie, J., Shi, S. D.-H., Bates, D., Min, X., Komorowski, R., Hager, T., Deng, L., Atangan, L., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aat3392 · Cited by 237
Gastric Inhibitory Polypeptide: the neglected incretin revisited
Meier, J. J., Nauck, M. A., Schmidt, W. E., & Gallwitz, B. (2002) · Regulatory Peptides · doi:10.1016/s0167-0115(02)00039-3 · Cited by 226
Zaragosi, L.-E., Wdziekonski, B., Brigand, K. L., Villageois, P., Mari, B., Waldmann, R., Dani, C., & Barbry, P. (2011) · Genome Biology · doi:10.1186/gb-2011-12-7-r64 · Cited by 225
Véniant, M. M., Lu, S.-C., Atangan, L., Komorowski, R., Stanislaus, S., Cheng, Y., Wu, B., Falsey, J. R., Hager, T., Thomas, V. A., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-023-00966-w · Cited by 218
Anti-obesity therapy: from rainbow pills to polyagonists
Müller, T. D., Clemmensen, C., Finan, B., DiMarchi, R. D., & Tschöp, M. H. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014803 · Cited by 199
Nyberg, J., Anderson, M. F., Meister, B., Alborn, A.-M., Ström, A.-K., Brederlau, A., Illerskog, A.-C., Nilsson, O., Kieffer, T. J., Hietala, M. A., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4920-04.2005 · Cited by 191
GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice
Hansotia, T., & Drucker, D. J. (2005) · Regulatory Peptides · doi:10.1016/j.regpep.2004.07.019 · Cited by 183
Althage, M. C., Ford, E. L., Wang, S., Tso, P., Polonsky, K. S., & Wice, B. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710466200 · Cited by 180
Chapter 15 Glucose‐Dependent Insulinotropic Polypeptide (Gastric Inhibitory Polypeptide; GIP)
McIntosh, C. H. S., Widenmaier, S., & Kim, S. (2009) · Vitamins & Hormones · doi:10.1016/s0083-6729(08)00615-8 · Cited by 171
Killion, E. A., Chen, M., Falsey, J. R., Sivits, G., Hager, T., Atangan, L., Helmering, J., Lee, J., Li, H., Wu, B., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18751-8 · Cited by 151
Deacon, C. F., Danielsen, P., Klarskov, L., Olesen, M., & Holst, J. J. (2001) · Diabetes · doi:10.2337/diabetes.50.7.1588 · Cited by 145
Targeting the glucagon receptor family for diabetes and obesity therapy
Cho, Y. M., Merchant, C. E., & Kieffer, T. J. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.05.009 · Cited by 156
Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effects
Bollag, R. J., Zhong, Q., Ding, K., Phillips, P., Zhong, L., Qin, F., Cranford, J., Mulloy, A. L., Cameron, R. S., & Isales, C. M. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00405-1 · Cited by 154
Song, D. H., Getty–Kaushik, L., Tseng, E., Simon, J., Corkey, B. E., & Wolfe, M. M. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.09.005 · Cited by 137
Glucose-dependent insulinotropic polypeptide modulates adipocyte lipolysis and reesterification
Getty‐Kaushik, L., Song, D. H., Boylan, M. O., Corkey, B. E., & Wolfe, M. M. (2006) · Obesity · doi:10.1038/oby.2006.129 · Cited by 134
“GIP has been shown to stimulate glucose transport and increase fatty acid synthesis in a concentration-dependent manner in fat tissue (12), and both lipoprotein lipase activity and fatty acid synthesis in fat tissue are enhanced in the presence of GIP (13).”
BackgroundIwasaki, K., Harada, N., Sasaki, K., Yamane, S., Iida, K., Suzuki, K., Hamasaki, A., Nasteska, D., Shibue, K., Joo, E., et al. (2015) · Endocrinology · doi:10.1210/en.2014-1653 · Cited by 132
Transforming obesity: The advancement of multi-receptor drugs
Kusminski, C. M., Perez-Tilve, D., Müller, T. D., DiMarchi, R. D., Tschöp, M. H., & Scherer, P. E. (2024) · Cell · doi:10.1016/j.cell.2024.06.003 · Cited by 126
Wachters-Hagedoorn, R. E., Priebe, M. G., Heimweg, J., Heiner, A. M., Englyst, K. N., Holst, J. J., Stellaard, F., & Vonk, R. J. (2006) · Journal of Nutrition · doi:10.1093/jn/136.6.1511 · Cited by 135
Nutrient detection by incretin hormone secreting cells
Diakogiannaki, E., Gribble, F. M., & Reimann, F. (2012) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.12.001 · Cited by 123
Disruption of GIP/GIPR axis in human adipose tissue is linked to obesity and insulin resistance
Ceperuelo-Mallafré, V., Duran, X., Pachón, G., Roche, K., Garrido-Sánchez, L., Vilarrasa, N., Tinahones, F. J., Vicente, V., Pujol, J., Vendrell, J., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3350 · Cited by 112
Knapper, J. M. E., Puddicombe, S. M., Morgan, L. M., & Fletcher, J. M. (1995) · The Journal of Nutrition · doi:10.1093/jn/125.2.183 · Cited by 109
Suzuki, K., Harada, N., Yamane, S., Nakamura, Y., Sasaki, K., Nasteska, D., Joo, E., Shibue, K., Harada, T., Hamasaki, A., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.423137 · Cited by 101
Glucose-dependent insulinotropic polypeptide (GIP): anti-diabetic and anti-obesity potential?
Gault, V. A., O'Harte, F. P. M., & Flatt, P. R. (2003) · Neuropeptides · doi:10.1016/j.npep.2003.09.002 · Cited by 107
Gabe, M. B. N., Sparre‐Ulrich, A. H., Pedersen, M. F., Gasbjerg, L. S., Inoue, A., Bräuner‐Osborne, H., Hartmann, B., & ROSENKILDE, M. M. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.01.040 · Cited by 96
Gögebakan, Ö., Osterhoff, M. A., Schüler, R., Pivovarova, O., Kruse, M., Seltmann, A.-C., Mosig, A. S., Rudovich, N., Nauck, M., & Pfeiffer, A. F. H. (2015) · Diabetologia · doi:10.1007/s00125-015-3618-4 · Cited by 95
Glucose-dependent insulinotropic polypeptide (GIP)
Müller, T. D., Adriaenssens, A. E., Ahrén, B., Blüher, M., Birkenfeld, A. L., Campbell, J. E., Coghlan, M. P., D’Alessio, D. D., Deacon, C. F., DelPrato, S., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102118 · Cited by 113
Rao, R. S., & Kini, S. U. (2010) · Obesity Surgery · doi:10.1007/s11695-010-0305-x · Cited by 103
Killion, E. A., Lu, S.-C., Fort, M., Yamada, Y., Véniant, M. M., & Lloyd, D. J. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnz002 · Cited by 94
Timper, K., Grisouard, J., Sauter, N. S., Herzog-Radimerski, T., Dembinski, K., Peterli, R., Frey, D. M., Zulewski, H., Keller, U., Müller, B., et al. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00100.2012 · Cited by 88
Hodge, D., Marsh, W. J., Parker, H. E., Ogunnowo-Bada, E., Riches, C. H., Habib, A. M., Evans, M. L., Gribble, F. M., & Reimann, F. (2012) · Diabetologia · doi:10.1007/s00125-012-2663-5 · Cited by 87
On the role of glucose-dependent insulintropic polypeptide in postprandial metabolism in humans
Asmar, M., Tangaa, W., Madsbad, S., Hare, K., Astrup, A., Flint, A., Bülow, J., & Holst, J. J. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00639.2009 · Cited by 83
Glucose-dependent insulinotropic polypeptide/gastric inhibitory polypeptide
Meier, J. J., & Nauck, M. A. (2004) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.08.007 · Cited by 82
McIntosh, C. H. S., Bremsak, I., Lynn, F. C., Gill, R., Hinke, S. A., Gelling, R., Nian, C., McKnight, G., Jaspers, S., & Pederson, R. A. (1999) · Endocrinology · doi:10.1210/endo.140.1.6464 · Cited by 73
“incorporation of both fatty acids (10) and glucose (14) into”
BackgroundGIP receptor mRNA expression in different fat tissue depots in postmenopausal non-diabetic women
Rudovich, N. N., Kaiser, S., Engeli, S., Osterhoff, M. A., Gögebakan, Ö., Blüher, M., & Pfeiffer, A. F. H. (2007) · Regulatory Peptides · doi:10.1016/j.regpep.2007.02.006 · Cited by 74
Inhibition of GIP signaling modulates adiponectin levels under high-fat diet in mice
Naitoh, R., Miyawaki, K., Harada, N., Mizunoya, W., Toyoda, K., Fushiki, T., Yamada, Y., Seino, Y., & Inagaki, N. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.08.052 · Cited by 76
Glucose-dependent insulinotropic polypeptide (GIP) and cardiovascular disease
Heimbürger, S. M., Bergmann, N. C., Augustin, R., Gasbjerg, L. S., Christensen, M. B., & Knop, F. K. (2020) · Peptides · doi:10.1016/j.peptides.2019.170174 · Cited by 67
Weaver, R. E., Donnelly, D., Wabitsch, M., Grant, P. J., & Balmforth, A. J. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.148 · Cited by 63
Speakman, J. R. (2013) · Human Heredity · doi:10.1159/000353585 · Cited by 68
GIP as a Potential Therapeutic Target for Atherosclerotic Cardiovascular Disease–A Systematic Review
Mori, Y., Matsui, T., Hirano, T., & Yamagishi, S.-I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041509 · Cited by 60
Glucose‐dependent insulinotropic polypeptide signaling in pancreatic β‐cells and adipocytes
McIntosh, C. H., Widenmaier, S., & Kim, S. (2012) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2012.00196.x · Cited by 57
Clinical evidence and mechanistic basis for vildagliptin's action when added to metformin
Åhrén, B., Foley, J. E., & Bosi, E. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01321.x · Cited by 64
Novel Therapeutical Approaches to Managing Atherosclerotic Risk
Giglio, R. V., Pantea Stoian, A., Al-Rasadi, K., Banach, M., Patti, A. M., Ciaccio, M., Rizvi, A. A., & Rizzo, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094633 · Cited by 54
Ceddia, R. P., & Collins, S. (2020) · Clinical Science · doi:10.1042/cs20190579 · Cited by 53
Ugleholdt, R., Pedersen, J., Bassi, M. R., Füchtbauer, E.-M., Jørgensen, S. M., Kissow, H.-L., Nytofte, N., Poulsen, S. S., Rosenkilde, M. M., Seino, Y., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.311779 · Cited by 49
Bates, H. E., Campbell, J. E., Ussher, J. R., Baggio, L. L., Maida, A., Seino, Y., & Drucker, D. J. (2012) · Diabetes · doi:10.2337/db11-1060 · Cited by 43
Maino, B., Ciotti, M. T., Calissano, P., & Cavallaro, S. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15045596 · Cited by 48
Glucose-Dependent Insulinotropic Polypeptide in Incretin Physiology: Role in Health and Disease
Wolfe, M. M., Boylan, M. O., & Chin, W. W. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf006 · Cited by 48
Pleiotropic Actions of the Incretin Hormones
McIntosh, C. H. S., Widenmaier, S. B., & Kim, S. (2010) · Vitamins and hormones · doi:10.1016/b978-0-12-381517-0.00002-3 · Cited by 46
GIP-Dependent Expression of Hypothalamic Genes
AMBATI, S., DUAN, J., HARTZELL, D. L., CHOI, Y.-H., DELLA-FERA, M. A., & BAILE, C. A. (2011) · Physiological Research · doi:10.33549/physiolres.932151 · Cited by 31
Matte, J. J., Ponter, A. A. A., & Sève, B. (1997) · Canadian Journal of Animal Science · doi:10.4141/a97-013 · Cited by 29
Razny, U., Kiec-Wilk, B., Polus, A., Goralska, J., Malczewska-Malec, M., Wnek, D., Zdzienicka, A., Gruca, A., Childs, C. E., Kapusta, M., et al. (2015) · BBA Clinical · doi:10.1016/j.bbacli.2015.05.001 · Cited by 27
“In vitro studies demonstrated that GIP influences lipid metabolism in 395 adipocytes from rodents [58] and humans [59] modifying lipogenesis [60] and 396 lipolysis [61-63].”
Fukuoka, D., Okahara, F., Hashizume, K., Yanagawa, K., Osaki, N., & Shimotoyodome, A. (2014) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00268.2014 · Cited by 30
Nakamura, T., Tanimoto, H., Mizuno, Y., Tsubamoto, Y., & Noda, H. (2012) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01555.x · Cited by 25
Ablation of Leptin Signaling to Somatotropes: Changes in Metabolic Factors that Cause Obesity
Akhter, N., Odle, A. K., Allensworth‐James, M. L., Haney, A. C., Syed, M., Cozart, M. A., Chua, S. C., Kineman, R. D., & Childs, G. V. (2012) · Endocrinology · doi:10.1210/en.2012-1331 · Cited by 25
New physiological effects of the incretin hormones GLP-1 and GIP.
Asmar, M. (2011) · PubMed · Cited by 29
Glucose-dependent insulinotropic polypeptide and its role in obesity
Song, D. H., & Wolfe, M. M. (2007) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328011aa88 · Cited by 24
Cho, G. J., Ryu, S. Y., Kim, Y. H., Kim, Y. S., Cheon, E. W., Park, J. M., Kim, H. J., Kang, S. S., & Choi, W. S. (2002) · Current Eye Research · doi:10.1076/ceyr.25.6.381.14238 · Cited by 22
Roe, J. A., Baba, A. S., Harper, J. M. M., & BUTTERY, P. J. (1995) · Comparative Biochemistry and Physiology Part A Physiology · doi:10.1016/0300-9629(94)00173-q · Cited by 19
Mucosal and hormonal adaptations after Roux-en-Y gastric bypass
Feris, F., MCRAE, A. N., Kellogg, T. A., McKenzie, T. J., Ghanem, O. M., & Acosta, A. J. (2022) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2022.08.020 · Cited by 22
Regulation of energy metabolism through central GIPR signaling
Liśkiewicz, A., & Müller, T. D. (2024) · Peptides · doi:10.1016/j.peptides.2024.171198 · Cited by 18
Baba, A. S., Harper, J. M. M., & BUTTERY, P. J. (2000) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/s0305-0491(00)00249-2 · Cited by 18
GIP-Based Therapeutics for Diabetes and Obesity
Gault, V. A., Irwin, N., & Flatt, P. R. (2008) · Current Chemical Biology · doi:10.2174/187231308783334108 · Cited by 17
De Fano, M., Malara, M., Vermigli, C., & Murdolo, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168650 · Cited by 17
“However, the presence of GIP-R on fat cells was shown in cell culture, animal and human models by gene expression and functional assays [103–105].”
BackgroundThe role of GIPR in food intake control
James-Okoro, P.-P., Lewis, J. E., Gribble, F. M., & Reimann, F. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1532076 · Cited by 23
Anti-atherosclerotic effect of incretin receptor agonists
Wang, X., Yang, X., Qi, X., Fan, G., Zhou, L., Peng, Z., & Yang, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1463547 · Cited by 22
Identification and characterization of adipose surface epitopes
Onogi, Y., Khalil, A., & Ussar, S. (2020) · Biochemical Journal · doi:10.1042/bcj20190462 · Cited by 16
Glucose-Dependent Insulinotropic Polypeptide (GIP)
Wolfe, M. M., Boylan, M. O., Kieffer, T. J., & Tseng, C. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-695-9_18 · Cited by 17
Bombesin and nutrients independently and additively regulate hormone release from GIP/Ins cells
Li, L., & Wice, B. M. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00346.2004 · Cited by 16
English, A. R., Craig, S. L., Flatt, P. R., & Irwin, N. (2020) · Biological Chemistry · doi:10.1515/hsz-2020-0195 · Cited by 14
Gao, Z., Yang, J., Liang, Y., Yang, S., Zhang, T., Gong, Z., & Li, M. (2022) · Obesity Surgery · doi:10.1007/s11695-022-05959-4 · Cited by 15
Pharmacological Advances in Incretin-Based Polyagonism: What We Know and What We Don’t
Novikoff, A., & Müller, T. D. (2024) · Physiology · doi:10.1152/physiol.00032.2023 · Cited by 15
Relling, A. E., Crompton, L. A., Loerch, S. C., & Reynolds, C. K. (2014) · Journal of Dairy Science · doi:10.3168/jds.2013-7574 · Cited by 11
Infection-elicited microbiota promotes host adaptation to nutrient restriction
Siqueira, M. K. D., Andrade‐Oliveira, V., Stacy, A., Guimarães, J. P. T., Alberca, R. W., Castoldi, Â., Santos, J. M., Davoli-Ferreira, M., Menezes-Silva, L., Turato, W. M., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2214484120 · Cited by 10
Brachs, S., Soll, D., Beer, F., Huckauf, N., Konkar, A. A., Spranger, J., Rütten, H., & Mai, K. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae151 · Cited by 7
Regulation of feeding and therapeutic application of bioactive peptides
Ueno, H., Zhang, W., & Nakazato, M. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108187 · Cited by 7
Privatananupunt, J., Watari, I., Podyma‐Inoue, K. A., Mizumachi-Kubono, M., & Ono, T. (2013) · Acta Histochemica · doi:10.1016/j.acthis.2013.11.007 · Cited by 8
Advances in Incretin‐Based Therapies for MAFLD: Mechanisms and Clinical Evidence
Dong, W., Zhang, H., Mu, S., Shi, S., Zhang, J., & Xu, K. (2025) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.70131 · Cited by 7
Nutritional hormones and the entero-osseous axis.
Isales, C. M., & Hamrick, M. W. (2008) · PubMed · Cited by 4
Curto, R., Giglione, C., Cannarella, R., Berisha, H., Hattab, R., Condorelli, R. A., Vignera, S. L., Calogero, A. E., & Magni, P. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108278 · Cited by 2
McCarty, M. F. (2003) · Medical Hypotheses · doi:10.1016/s0306-9877(03)00226-3 · Cited by 1
Wabitsch, M., Fuchs, M., Horenburg, S., Denzer, C., von Puttkamer, J., Moß, A., Lahr, G., & Fischer‐Posovszky, P. (2008) · KARGER eBooks · doi:10.1159/000158563
Role of gastrointestinal hormones in the metabolic dysfunction in obesity and associated diseases
Rudovich, N. N. (2011) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-7245
Glucose-dependent insulinotropic polypeptide lowers branched chain amino acids in hyperglycemic rats
Spégel, P., Lindqvist, A., Sandberg, M., & Wierup, N. (2014) · Regulatory Peptides · doi:10.1016/j.regpep.2013.12.009 · Cited by 3
Functional analysis of glucose-dependent insulinotropic polypeptide fusion proteins
Ding, K.-H., Isales, C. M., Zhong, Q., & Bollag, R. J. (2001) · Peptides · doi:10.1016/s0196-9781(01)00366-7
GASTRIC INHIBITORY POLYPEPTIDE IN THE BRAIN
Nyberg, J. (2009) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Widenmaier, S. B. (2010) · cIRcle (University of British Columbia) · doi:10.14288/1.0071070
Merchant, C. E. (2011) · cIRcle (University of British Columbia) · doi:10.14288/1.0105089
Nutritional Approaches and Gastrointestinal Health and Physiology
Saqui–Salces, M. (2014) · University of Minnesota Digital Conservancy (University of Minnesota)
Metadata
- Authors
- Hauner, H., Glatting, G., Kaminska, D., & Pfeiffer, E. F.
- Affiliations
- Universität Ulm (DE)
- Venue
- Annals of Nutrition and Metabolism
- Publisher
- S. Karger AG
- Published
- 1988
- Volume
- 32
- Issue
- 5-6
- Pages
- 282-288
- ISSN
- 0250-6807 (ISSN-L)
- 1421-9697
- OpenAlex
- W2047798798
- Cited by
- 98
- References
- 0
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 7 · 2023: 1 · 2022: 3 · 2021: 3 · 2020: 6 · 2019: 2 · 2018: 5 · 2015: 2 · 2014: 7 · 2013: 3 · 2012: 7
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Nutrition and Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- glucose-dependent insulinotropic polypeptide, adipocytes, glucose metabolism, lipid metabolism, glucose transport, lipogenesis, insulin-like activity, insulin receptor affinity, lipolysis, glucagon, isoproterenol, obesity
- MeSH terms
- Adipose Tissue, Animals, Biological Transport, Dose-Response Relationship, Drug, Gastric Inhibitory Polypeptide, Glucagon, Glucose, Insulin, Isoproterenol, Lipolysis, Male, Rats, Inbred Strains, Receptor, Insulin, Lipid Metabolism, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.